The main goal of Claas's project is to determine the relationship between differentiation potential and immune modulatory function in clonally-selected MSCs of mouse and human.
Mikey's research is in examining the role of modified human endothelial progenitor cells and mesenchynal stem cells in the treatment of cardiovasuclar disease.